Skip to main content
. 2021 Aug;12(4):1285–1300. doi: 10.21037/jgo-21-185

Table 3. Estimated AUC of AJCC N factor, LNR and LODDS for OS at 1, 3, 5 and 10 years in young patients with gastric cancer.

AUC of AJCC N factor (95% CI) AUC of LNR (95% CI) AUC of LODDS (95% CI) P1 P2
All-case analysis
   1 year 0.628 (0.597–0.658) 0.694 (0.652–0.737) 0.703 (0.661–0.745) <0.001* <0.001*
   3 years 0.657 (0.624–0.690) 0.698 (0.663–0.733) 0.701 (0.665–0.736) 0.030* 0.019*
   5 years 0.682 (0.645–0.720) 0.694 (0.658–0.731) 0.707 (0.671–0.743) 0.548 0.216
   10 years 0.672 (0.602–0.741) 0.666 (0.606–0.725) 0.677 (0.617–0.736) 0.858 0.881
In patients with ≤15 examined LNs
   1 year 0.643 (0.590–0.696) 0.638 (0.574–0.702) 0.646 (0.582–0.709) 0.867 0.922
   3 years 0.675 (0.623–0.728) 0.682 (0.628–0.736) 0.685 (0.631–0.739) 0.792 0.687
   5 years 0.726 (0.669–0.782) 0.687 (0.632–0.743) 0.700 (0.644–0.755) 0.128 0.296
   10 years 0.695 (0.598–0.793) 0.641 (0.550–0.731) 0.652 (0.561–0.743) 0.156 0.254

AUC, area under the curve; LNR, lymph node ratio; LODDS, the log odds of positive lymph nodes; CI, confidence interval; LN, lymph node. *indicate significant P values. , P1 value: AUC of AJCC N factor vs. AUC of LNR. , P2 value: AUC of AJCC N factor vs. AUC of LODDS.